{"id":22876,"date":"2022-07-14T15:31:58","date_gmt":"2022-07-14T13:31:58","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=22876"},"modified":"2022-07-14T15:32:22","modified_gmt":"2022-07-14T13:32:22","slug":"novavax-vakcina-jau-gali-buti-skiepijami-vaikai-nuo-12-metu-amziaus","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2022\/07\/14\/novavax-vakcina-jau-gali-buti-skiepijami-vaikai-nuo-12-metu-amziaus\/","title":{"rendered":"\u201eNovavax\u201c vakcina jau gali b\u016bti skiepijami vaikai nuo 12 met\u0173 am\u017eiaus"},"content":{"rendered":"

Atsi\u017evelgdama \u012f Europos vaist\u0173 agent\u016bros (EMA) rekomendacij\u0105, Europos Komisija pakeit\u0117 COVID-19 vakcinos \u201eNovavax\u201c (gamintojas \u201eNuvaxovid\u201c) registracijos s\u0105lygas ir leido ja skiepyti vaikus nuo 12 met\u0173\u00a0am\u017eiaus. Registruotis vakcinacijai bus galima nuo 2022 m. liepos 15 d.<\/strong><\/p>\n

\u201eNovavax\u201c vakcina 12\u201317 met\u0173 am\u017eiaus vaikams bus skiriama taip pat kaip 18 met\u0173 ir vyresniems asmenims: vakcina bus suleid\u017eiama \u012f \u017easto raumenis dviej\u0173 dozi\u0173 kursu, darant 3 savai\u010di\u0173 pertrauk\u0105. Registruotis vakcinacijai galima, registruojantis internetu tinklalapyje Koronastop.lt<\/a>.<\/p>\n

Iki \u0161iol \u201eNovavax\u201c vakcina buvo skiepijami tik asmenys nuo 18 met\u0173 am\u017eiaus. Leisti skiepyti jaunesnius asmenis nuspr\u0119sta po klinikinio tyrimo, kuris parod\u0117, kad paaugli\u0173 imuninis atsakas \u012f \u0161i\u0105 vakcin\u0105, matuojamas kaip antik\u016bn\u0173 prie\u0161 SARS-CoV-2 kiekis, buvo pana\u0161us \u012f 18\u201325 met\u0173 am\u017eiaus jaun\u0173 suaugusi\u0173j\u0173 (kurie dalyvavo pagrindiniame tyrime, naudotame vertinant vakcinos veiksmingum\u0105 suaugusiesiems) atsak\u0105.<\/p>\n

Da\u017eniausios nepageidaujamos reakcijos paaugliams da\u017eniausiai yra pana\u0161ios \u012f tas, kurios pasirei\u0161kia 18 met\u0173 am\u017eiaus ir vyresniems \u017emon\u0117ms. Tai \u2013 jautrumas, skausmas, paraudimas ir patinimas injekcijos vietoje, galvos, raumen\u0173 ir s\u0105nari\u0173 skausmas, nuovargis, pykinimas ar v\u0117mimas, kar\u0161\u010diavimas ir kt. Kar\u0161\u010diavimas paaugliams pasirei\u0161kia da\u017eniau nei suaugusiesiems. \u0160ios reakcijos da\u017eniausiai b\u016bna lengvos arba vidutinio sunkumo ir praeina po keleto dien\u0173.<\/p>\n

Pla\u010diau apie nepageidaujamas reakcijas ir klinikin\u012f tyrim\u0105 skaitykite EMA prane\u0161ime<\/a>.<\/p>\n

Primename, kad asmenims nuo 12 met\u0173 am\u017eiaus \u0161iuo metu gali b\u016bti skiriamos trys vakcinos nuo COVID-19: \u201eComirnaty\u201c, \u201eSpikevax\u201c ir \u201eNovavax\u201c.<\/p>\n

SAM Spaudos tarnyba<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Atsi\u017evelgdama \u012f Europos vaist\u0173 agent\u016bros (EMA) rekomendacij\u0105, Europos Komisija pakeit\u0117 COVID-19 vakcinos \u201eNovavax\u201c (gamintojas \u201eNuvaxovid\u201c) registracijos s\u0105lygas ir leido ja skiepyti vaikus nuo 12 met\u0173\u00a0am\u017eiaus. Registruotis vakcinacijai bus galima nuo 2022 m. liepos 15 d. \u201eNovavax\u201c vakcina 12\u201317 met\u0173 am\u017eiaus vaikams bus skiriama taip pat kaip 18 met\u0173 ir vyresniems asmenims: vakcina bus suleid\u017eiama \u012f…<\/p>\n","protected":false},"author":3,"featured_media":22877,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-22876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-5WY","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2022\/07\/20433_1693ea76f8073bff2c142889b21b481f.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/22876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=22876"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/22876\/revisions"}],"predecessor-version":[{"id":22878,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/22876\/revisions\/22878"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/22877"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=22876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=22876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=22876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}